LEICA BIOSYSTEMS NEWCASTLE LIMITED

Get an alert when LEICA BIOSYSTEMS NEWCASTLE LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-02-03 (in 9mo)

Last made up 2026-01-20

Watchouts

None on the register

Cash

£37M

-50.8% vs 2023

Net assets

£201M

+11.9% vs 2023

Employees

314

+2.6% vs 2023

Profit before tax

£119M

+1% vs 2023

Name history

Renamed 2 times since incorporation

LEICA BIOSYSTEMS NEWCASTLE LIMITED 2007-09-17 → present
NOVOCASTRA LABORATORIES LIMITED 1989-05-22 → 2007-09-17
SPACECLAM LIMITED 1987-09-10 → 1989-05-22

Net assets

2-year trend · vs Industrials median

LEICA BIOSYSTEMS NEWCASTLE LIMITED·Industrials median · n=6236

Accounts

2-year trend · latest reflected 2024-12-31

Metric	2023-12-31	2024-12-31
Turnover	£168,837,000	£179,347,000
Operating profit	£112,228,000	£114,086,000
Profit before tax	£117,944,000	£119,114,000
Net profit	£119,047,000	£121,346,000
Cash	£74,492,000	£36,626,000
Total assets less current liabilities	£201,112,000	£224,491,000
Net assets	£180,080,000	£201,426,000
Equity	£180,080,000	£201,426,000
Average employees	306	314
Wages	£15,252,000	£16,095,000

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio	2023-12-31	2024-12-31
Operating margin	66.5%	63.6%
Net margin	70.5%	67.7%
Return on capital employed	55.8%	50.8%
Current ratio	6.41x	4.18x
Interest cover	91.69x	78.79x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis: FRS 101
Reporting scope: Standalone (parent only)
Auditor: Ernst & Young LLP
Audit opinion: Unqualified (clean)
Going concern: Affirmed
“After making due enquiries and considering the impact of the geo-political environment, general economic inflationary pressure and the access to funds, cross guarantees with fellow members of the UK Group cash pool, and ultimately strength of its balance sheet, the directors have a reasonable expectation that the Company has adequate resources to continue in operation during the assessment period to 31 December 2026. These considerations include the company, as well as the wider UK and Danaher Corporation group. Accordingly, the financial statements have been prepared on the going concern basis.”

Group structure

LEICA BIOSYSTEMS NEWCASTLE LIMITED · parent
1. Leica Cambridge Limited 100% · England & Wales

Significant events

“On March 21st, 2025 the company acquired the Cell IDX business for $10.5m.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 32 resigned

Name	Role	Appointed	Born	Nationality
BELL, Joe Anthony	Director	2024-08-14	Apr 1988	British
JOHNSON, Sarah Margaret	Director	2023-02-13	Oct 1975	British
VAN DER MERWE, Gillian	Director	2019-06-17	Mar 1972	British

Show 32 resigned officers

Name	Role	Appointed	Resigned
ANGUS, Brian, Dr	Secretary	—	1992-05-01
MCGRAW, David John	Secretary	2002-06-25	2007-07-06
PIZZEY, Charles Euan	Secretary	2002-06-26	2007-02-12
THURGAR-DAWSON, Colin Joseph	Secretary	1992-05-01	1993-09-15
THURGAR-DAWSON, Colin Joseph	Secretary	—	2002-06-25
TUNLEY, David William	Secretary	2007-07-06	2012-06-29
ANGUS, Brian, Dr	Director	—	2002-06-25
ATKINS, David George, Dr	Director	2014-07-11	2015-04-23
BUDD, David	Director	2015-05-07	2016-02-29
BUDD, David	Director	2013-07-01	2014-07-11
BURNS, Alastair	Director	2013-04-19	2016-06-01
CROMBIE, Alexander Leaster, Professor	Director	1993-06-03	2002-06-25
ELSTOB, Steven	Director	2022-08-05	2024-06-25
FIEDLER, Konstantin Alexander	Director	2011-07-04	2013-05-31
FLEETHAM, Anne	Director	2007-07-06	2011-02-14
FOX, James Charles, Dr	Director	2002-06-26	2006-12-22
GARRETT, Sarah	Director	2018-09-10	2022-07-19
HORNE, Agnes Irvine	Director	1993-09-29	2002-06-25
HORNE, Charles Hugh Wilson, Professor	Director	—	2005-06-21
HUNTER, Michael	Director	2011-02-04	2012-12-21
INMAN, David George White	Director	2016-06-01	2018-09-10
LANYON, Samuel Ross Garland	Director	2007-07-06	2008-09-02
MILTON, Ian David	Director	2001-06-01	2011-10-12
OHANESSIAN, Michael Bernard	Director	2002-06-26	2006-08-30
PIZZEY, Charles Euan	Director	2002-06-26	2007-02-12
REID, Vicky	Director	2017-07-21	2019-06-17
TOMS, Geoffrey Leonard, Dr	Director	—	2002-06-25
WARD, Keith Graham	Director	2008-09-02	2016-10-01
WEST, Matthew William	Director	2016-10-01	2023-02-13
WHITE, Colin Craig	Director	2016-03-01	2017-07-21
WHITTAKER, Roy	Director	—	1992-01-27
WRIGHT, Paul Martin	Director	2006-11-09	2007-07-06

Ownership

Persons with significant control

Name	Kind	Nature of control	Notified	Status
Launchchange Operations Ltd	Corporate entity	Shares 75–100%, Voting 75–100%, Appoints directors	2017-01-20	Active

Filing timeline

Last 20 of 190 total filings

Date	Type	Category	Description
2026-01-25	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2025-07-18	AA	accounts	Accounts with accounts type full
2025-01-29	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2024-08-31	AA	accounts	Accounts with accounts type full
2024-08-23	AP01	officers	Appoint person director company with name date	PDF
2024-07-03	TM01	officers	Termination director company with name termination date	PDF
2024-02-02	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2023-10-04	AA	accounts	Accounts with accounts type full
2023-10-03	AD01	address	Change registered office address company with date old address new address	PDF
2023-10-03	AD01	address	Change registered office address company with date old address new address	PDF
2023-02-27	AP01	officers	Appoint person director company with name date	PDF
2023-02-24	TM01	officers	Termination director company with name termination date	PDF
2023-01-23	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2022-08-05	AP01	officers	Appoint person director company with name date	PDF
2022-07-27	TM01	officers	Termination director company with name termination date	PDF
2022-07-20	AA	accounts	Accounts with accounts type full
2022-01-28	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2021-09-05	AA	accounts	Accounts with accounts type full
2021-02-11	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2020-12-16	AA	accounts	Accounts with accounts type full

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings: 2
Capital events: 0
Officers appointed: 0
Officers resigned: 0

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Turnover

+6.2%

£168,837,000 £179,347,000
Cash

-50.8%

£74,492,000 £36,626,000
Net assets

+11.9%

£180,080,000 £201,426,000
Employees

+2.6%

306 314
Operating profit

+1.7%

£112,228,000 £114,086,000
Profit before tax

+1%

£117,944,000 £119,114,000
Wages

+5.5%

£15,252,000 £16,095,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page